BA/BE Studies on Healthy Volunteers

BrillexBrillex CRO specializes in conducting BA/BE and Phase I studies in healthy volunteers with scientific precision and strict regulatory compliance. With a state-of-the-art 160 bedded clinical facility with well-equipped ICU to handle emergencies and advanced Bioanalytical laboratory with LCMS/MS, We deliver reliable data to support your product’s successful market entry.

End to End BA BE Studies
Feasibility, Study design and Protocol development
Study Conduct with top notch expertise
Method development and Validation
Sample Analysis using Advanced LC-MS/MS
Pharmacokinetic and Statistical Analysis
Regulatory Submission and Compliance support

Bioavailability & Bioequivalence (BA/BE) Studies

Explore Services

Clinical Trial Management (Phase I - IV) on Patients

Pharmacovigilance & Safety Services

Regulatory Affairs & Quality Compliance

Medical Writing & Scientific Support

Data Management & Biostatistics

Site & Patient Recruitment Support

Clinical Trial Logistics & Supply Chain

Real-World Evidence & Decentralized Trials

Nitrosamine Testing Services

Inquiry Now!

(+91)

+93 Afghanistan
+355 Albania
+213 Algeria
+1684 American Samoa
+376 Andorra
+244 Angola
+1264 Anguilla
+672 Antarctica
+1268 Antigua And Barbuda
+54 Argentina
+374 Armenia
+297 Aruba
+61 Australia
+43 Austria
+994 Azerbaijan
+1242 Bahamas The
+973 Bahrain
+880 Bangladesh
+1246 Barbados
+375 Belarus
+32 Belgium
+501 Belize
+229 Benin
+1441 Bermuda
+975 Bhutan
+591 Bolivia
+387 Bosnia and Herzegovina
+267 Botswana
+55 Brazil
+246 British Indian Ocean Territory
+673 Brunei
+359 Bulgaria
+226 Burkina Faso
+257 Burundi
+855 Cambodia
+237 Cameroon
+1 Canada
+238 Cape Verde
+1345 Cayman Islands
+236 Central African Republic
+235 Chad
+56 Chile
+86 China
+61 Christmas Island
+672 Cocos (Keeling) Islands
+57 Colombia
+269 Comoros
+242 Congo
+242 Congo The Democratic Republic Of The
+682 Cook Islands
+506 Costa Rica
+225 Cote D'Ivoire (Ivory Coast)
+385 Croatia (Hrvatska)
+53 Cuba
+357 Cyprus
+420 Czech Republic
+45 Denmark
+253 Djibouti
+1767 Dominica
+1809 Dominican Republic
+593 Ecuador
+20 Egypt
+503 El Salvador
+240 Equatorial Guinea
+291 Eritrea
+372 Estonia
+251 Ethiopia
+500 Falkland Islands
+298 Faroe Islands
+679 Fiji Islands
+358 Finland
+33 France
+594 French Guiana
+689 French Polynesia
+241 Gabon
+220 Gambia The
+995 Georgia
+49 Germany
+233 Ghana
+350 Gibraltar
+30 Greece
+299 Greenland
+1473 Grenada
+590 Guadeloupe
+1671 Guam
+502 Guatemala
+224 Guinea
+245 Guinea-Bissau
+592 Guyana
+509 Haiti
+504 Honduras
+852 Hong Kong S.A.R.
+36 Hungary
+354 Iceland
+91 India
+62 Indonesia
+98 Iran
+964 Iraq
+353 Ireland
+972 Israel
+39 Italy
+1876 Jamaica
+81 Japan
+962 Jordan
+7 Kazakhstan
+254 Kenya
+686 Kiribati
+850 Korea North
+82 Korea South
+965 Kuwait
+996 Kyrgyzstan
+856 Laos
+371 Latvia
+961 Lebanon
+266 Lesotho
+231 Liberia
+218 Libya
+423 Liechtenstein
+370 Lithuania
+352 Luxembourg
+853 Macau S.A.R.
+389 Macedonia
+261 Madagascar
+265 Malawi
+60 Malaysia
+960 Maldives
+223 Mali
+356 Malta
+692 Marshall Islands
+596 Martinique
+222 Mauritania
+230 Mauritius
+269 Mayotte
+52 Mexico
+691 Micronesia
+373 Moldova
+377 Monaco
+976 Mongolia
+1664 Montserrat
+212 Morocco
+258 Mozambique
+95 Myanmar
+264 Namibia
+674 Nauru
+977 Nepal
+599 Netherlands Antilles
+31 Netherlands The
+687 New Caledonia
+64 New Zealand
+505 Nicaragua
+227 Niger
+234 Nigeria
+683 Niue
+672 Norfolk Island
+1670 Northern Mariana Islands
+47 Norway
+968 Oman
+680 Palau
+970 Palestinian Territory Occupied
+507 Panama
+675 Papua new Guinea
+595 Paraguay
+51 Peru
+63 Philippines
+64 Pitcairn Island
+48 Poland
+351 Portugal
+1787 Puerto Rico
+974 Qatar
+262 Reunion
+40 Romania
+70 Russia
+250 Rwanda
+290 Saint Helena
+1869 Saint Kitts And Nevis
+1758 Saint Lucia
+508 Saint Pierre and Miquelon
+1784 Saint Vincent And The Grenadines
+684 Samoa
+378 San Marino
+239 Sao Tome and Principe
+966 Saudi Arabia
+221 Senegal
+248 Seychelles
+232 Sierra Leone
+65 Singapore
+421 Slovakia
+386 Slovenia
+677 Solomon Islands
+252 Somalia
+27 South Africa
+500 South Georgia
+34 Spain
+94 Sri Lanka
+249 Sudan
+597 Suriname
+47 Svalbard And Jan Mayen Islands
+268 Swaziland
+46 Sweden
+41 Switzerland
+963 Syria
+886 Taiwan
+992 Tajikistan
+255 Tanzania
+66 Thailand
+228 Togo
+690 Tokelau
+676 Tonga
+1868 Trinidad And Tobago
+216 Tunisia
+90 Turkey
+7370 Turkmenistan
+1649 Turks And Caicos Islands
+688 Tuvalu
+256 Uganda
+380 Ukraine
+971 United Arab Emirates
+44 United Kingdom
+1 United States
+1 United States Minor Outlying Islands
+598 Uruguay
+998 Uzbekistan
+678 Vanuatu
+39 Vatican City State (Holy See)
+58 Venezuela
+84 Vietnam
+1284 Virgin Islands (British)
+1340 Virgin Islands (US)
+681 Wallis And Futuna Islands
+212 Western Sahara
+967 Yemen
+260 Zambia
+263 Zimbabwe

Bioavailability & Bioequivalence (BA/BE) Studies

Explore Services

Inquiry Now!

Discover More

/

brillex-clinical-research-pvt-ltd